Stock TVGN TEVOGEN BIO HOLDINGS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Tevogen Bio Holdings Inc.

Equities

TVGN

US88165K1016

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-06-12 pm EDT 		5-day change 1st Jan Change
0.87 USD -0.25% Intraday chart for Tevogen Bio Holdings Inc. +10.87% -92.18%
Jun. 06 Tevogen Bio Confirms Ongoing Efficacy of Tvgn 489, Its Investigational Allogeneic Off-The-Shelf Immunotherapy, Against Dominant Flirt Strains of Sars-Cov-2 CI
May. 13 Investors Eye Key Inflation Data in Days Ahead as US Futures Trend Modestly Higher Monday MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Tevogen Bio Confirms Ongoing Efficacy of Tvgn 489, Its Investigational Allogeneic Off-The-Shelf Immunotherapy, Against Dominant Flirt Strains of Sars-Cov-2
CI
Top Premarket Gainers
MT
Sector Update: Health Care Stocks Higher in Afternoon Trading
MT
Tevogen Bio Shares Jump Following Report on $94.9 Million Liability Elimination
MT
Top Premarket Gainers
MT
Tevogen Bio Holdings Announces TVGN 489, its Investigational SARS-CoV-2 Specific T Cell Therapy, TVGN-489, Retains Activity Against the Dominant JN.1 Variant
CI
Tevogen Bio Holdings Inc. Prepares to Launch Crucial Genetic Predisposition Study in Preparation to Investigate the Potential of TVGN 489 to Address Critical Unmet Need for Long COVID Treatment
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TVGN Stock
  4. News Tevogen Bio Holdings Inc.
  5. Highlights